Connect® MDS/AML Disease Registry
Connect Myeloid: The Myelofibrosis (MF), Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry
-
Clinical Trial Information
Trial Contact: Britton, David ; Rodriguez Saavedra, Carlis M
Trial Phone: 321.841.2684 ; 321.841.6764
-
IRB No: 13.144.09
Protocol Abbrev: Connect MDS
Principal Investigator: Daniel Ari Landau, MD
Age Group: Adult
Secondary Protocol No: AZA-MDS-006
ClinicalTrials.gov ID: NCT01688011
-
Objective
The purpose of the registry is to provide insights into treatment regimens of patients with newly diagnosed MDS or AML
-
Key Eligibility
AML or MDS newly diagnosed
Share:
